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ABSTRACT
Objectives The aim of the study was to investigate the
spatial and temporal relationships between the prevalence
of COVID-19 symptoms in the community-level and area-
level social deprivation.
Design Spatial mapping, generalised linear models, using
time as a factor and spatial-lag models were used to
explore the relationship between self-reported COVID-19
symptom prevalence as recorded through two smartphone
symptom tracker apps and a range of socioeconomic
factors using a repeated cross-sectional study design.
Setting In the community in Northern Ireland, UK. The
analysis period included the earliest stages of non-
pharmaceutical interventions and societal restrictions or
‘lockdown’ in 2020.
Participants Users of two smartphone symptom tracker
apps recording self-reported health information who
recorded their location as Northern Ireland, UK.
Primary outcome measures Population standardised
self-reported COVID-19 symptoms and correlation
between population standardised self-reported COVID-19
symptoms and area-level characteristics from measures
of multiple deprivation including employment levels and
population housing density, derived as the mean number
of residents per household for each census super output
area.
Results Higher self-reported prevalence of COVID-19
symptoms was associated with the most deprived
areas (p<0.001) and with those areas with the lowest
employment levels (p<0.001). Higher rates of self-reported
COVID-19 symptoms within the age groups, 18–24
and 25–34 years were found within the most deprived
areas during the earliest stages of non-pharmaceutical
interventions and societal restrictions (‘lockdown’).
Conclusions Through spatial regression of self-reporting
COVID-19 smartphone data in the community, this
research shows how a lens of social deprivation can
deepen our understanding of COVID-19 transmission and
prevention. Our findings indicate that social inequality, as
measured by area-level deprivation, is associated with
disparities in potential COVID-19 infection, with higher
prevalence of self-reported COVID-19 symptoms in urban

Strengths and limitations of this study
►► The geographical spread of the self-reporting partic-

ipants using the smartphone apps was investigated
through spatial mapping and regression using time
as a factor.
►► The use of two apps from different smartphone app
providers enabled a broad sampling of the general
population using a repeated cross-sectional study
design.
►► The predicted variable in the study is the reporting of
COVID-19 symptoms rather than true disease prevalence and therefore caution must be exercised in
interpreting the results.
►► Nevertheless, the results may inform the search for
effective interventions to reduce health inequalities and improve prevention of COVID-19 in the
population.

areas associated with area-level social deprivation,
housing density and age.

INTRODUCTION
Measuring and managing transmission of the
novel SARS-CoV-2 virus has presented public
health authorities and policy-
makers with
considerable challenges during the evolution
of the COVID-19 pandemic.1 The variety of
approaches adopted by different countries for
monitoring the spread of the virus, included
spatiotemporal epidemiology, contagion
risk models and monitoring platforms,2–5 to
inform their policy responses. Measurement
of the number of cases is key to monitoring
transmission, risk assessment and evaluating
the effectiveness of non-pharmaceutical societal interventions. National agencies record
data on numbers of COVID-19 positive tests,
hospital admissions and deaths, but these are
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METHODS
The current study concentrates on the reporting period
24 March 2020–22 June 2020 at the earliest stages of non-
pharmaceutical interventions and societal restrictions
(‘lockdown’), when viral or other positive testing methods
were not widely available.11 A repeated cross-
sectional
study design using self-
reported COVID-19 symptoms
smartphone apps provided a way to track the spatial and
temporal spread of the virus through Northern Ireland
2

(NI) by self-
reported health information from both
asymptomatic and symptomatic individuals.
In the UK, administrations in England, Scotland, Wales
and NI have responsibility for public health functions,
including most aspects of responding to the COVID-19
pandemic. Our study setting is NI, one of the devolved
UK nations, with an estimated mid-year population of
1 893 700 (30 June 2019).26 Two major symptom tracking
apps were available and used in NI. The UK COVID-19
symptom tracker was developed by King’s College London
(KCL) and the health science company ZOE (https://
COVID-19.joinzoe.com/) and is available to download
throughout the UK.10 The NI Health and Social Care
(HSC) service launched its own symptom tracker app,
COVIDCare NI (formerly known as ‘COVID-19 NI’), on
620April 2020. The COVIDCare NI symptom checker app,
developed primarily as part of a triage system, provided
advice for users on whether they should self-isolate and/
or seek medical assistance. The UK KCL ZOE symptom
tracker app provided data for NI for the current study
for the period (24 March 2020–22 June 2020) whereas
the HSC NI Symptom checker feature (COVIDCare NI)
provided data for the reporting period 6 April 2020–22
June 2020. Smartphone ownership does not vary significantly by urban or rural location in NI and shows a strong
alignment with UK prevalence.27 In 2019, 76% of adults
in the UK reported smartphone ownership.28
Data from both smartphone symptom tracking apps
were generated on a series of 7 and 14 day periods, known
as sliding windows. Each period contained: (1) total individual active users who have used the COVID-19 symptom
checking/recording features and (2) total individual
users recording an assessment, with symptoms meeting
the classic (new continuous cough or high temperature)
or refined (new continuous cough or high temperature
or anosmia) Public Health England (PHE) COVID-19
case definitions.29 There are some differences between
the two symptom tracker apps especially with the ‘new’
PHE definition which included anosmia. These are:1)
The symptom of anosmia was included in the KCL
ZOE symptom tracker app from the start but was only
included later in the presumptive positive definition. In
this research study, we, therefore, refer to classic (new
continuous cough or high temperature) or refined symptoms (new continuous cough or high temperature or
anosmia) as defined by PHE; (2) The COVIDcare NI app
initially included anosmia as a symptom which could only
be reported if one of the traditional symptoms was also
present. The definition was changed at the same time as
the KCL ZOE symptom tracker app refined the symptoms
in line with PHE guidelines.29 In summary both symptom
tracker apps provide a cross sectional study but may
not be sampling the same repeated cross section of the
population of NI. Therefore, the symptom tracker app
data sets were not combined in the analysis but instead a
comparative analysis was provided.
Both tracker apps require recording a location. As the
period of the analysis coincided with the first societal
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333
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biased towards the higher parts of the epidemiological
pyramid,6 representing mainly people with more severe
disease and timely access to testing. The challenge during
the COVID-19 pandemic has been recording those in
the community with mild symptoms who may not seek
care or be able to access testing. Moreover, the number
of infected people in the community depends on individual and social behaviours and these data have been
more difficult to record. The introduction of COVID-19
symptom trackers as free smartphone apps (launched in
UK 24 March 2020 and US 29 March 2020) provided a
way to track in real time how the virus might be transmitting by recording self-
reported health information
from both asymptomatic and symptomatic individuals
on a daily basis.7–10 At this stage in the pandemic, during
the earliest stages of non-pharmaceutical interventions,
viral or other positive testing methods were not widely
available.11 However, the COVID-19 symptom trackers
provided a way to record self-reported health information
from both non-symptomatic and symptomatic individuals
in the community.
The importance of the link between health and place
is widely recognised.12 Health inequalities are defined as
differences in health across the population, and between
different groups within society.13 An interplay of factors at
multiple levels can influence health inequalities, including
the physical and socioeconomic environment.14–17 Limitations in data sampling, data collection and analysis techniques have constrained our understanding of the causes
of these disparities.18 This has hindered the opportunity
to provide evidence for effective interventions to reduce
these disparities and improve overall health outcomes.
Health inequalities have been documented between
population groups across socioeconomic status and deprivation, vulnerable groups of society or ‘inclusion health’
groups and geography.13 The main driver for these differences is contact networks which arise as a function of social
behaviour (culture) and urban and rural geographies. It
is now recognised that the COVID-19 crisis has disproportionately affected certain at-risk communities, based on
their previous health, socioeconomic position and ethnic
characteristics.19–25 While most of the clinical research
has reported on people experiencing severe illness, in
this research we investigate the spatial and temporal relationships between the prevalence of COVID-19 symptoms
in the community and area-level social deprivation using
a repeated cross-sectional study design.
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restrictions (‘lockdown’) in NI, it is reasonable to assume
that for most people this would have been their home
location. The KCL ZOE symptom tracker app report is
linked to one distinct individual record. The COVIDcare
NI app records events without specific individuals. The
authors introduced a pseudo-individual marker based on
a combination of individual factors (handset used, age,
gender) which proved to be very effective in providing
distinctive records. Therefore, in the current study we
assume that for both apps a COVID-symptomatic individual has been included once. For this research study,
both symptom tracker app datasets were analysed at
super output area (SOA) level. The KCL ZOE tracker
app generates data geocoded to SOAs, while in the case
of COVIDCare NI, data were converted from postal code
to SOAs by the authors. Data containing invalid postcodes or postcodes outside of NI were removed during

this postprocessing. There are 890 SOA administrative
areas across NI.30 When the numbers of users or those
reporting symptoms (from either app) were too small in
any SOA (n≤5) these small cell counts were suppressed to
avoid disclosure risk. By ‘reporting symptoms’ we mean
that, on any given date, symptoms would have satisfied
the PHE case definition.29
Area-
level deprivation was characterised using the
orthern Ireland Multiple Deprivation Measures 2017
(NIMDM) provided by the Northern Ireland Statistics and
Research Agency (NISRA; figure 1).30 The NIMDMs are
derived from the 2011 census and were made available by
the NISRA in 2017. The 2011 census is currently the most
comprehensive population census for NI. Results for
the next census are not yet available31 as it took place in
March 2021. The NIMDMs provide information on seven
individual domains of deprivation and an overall score

Figure 2 Smartphone symptom tracker app user demographic profile compared with the population profile of NI. Self-
reporting COVID-19 symptom data provided by the KCl ZOE symptom tracker app data for NI (reporting period 24 March 2020–
22 June 2020) and COVIDCare NI symptom checker feature, (reporting period 6 April–22 June 2020). NI, Northern Ireland.
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333
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Figure 1 Northern Ireland Multiple Deprivation Measures 2017 (NIMDM) provided by the Northern Ireland Statistics and
Research Agency30 including information on overall social deprivation MDMs ranking (A) for NI and (B) for Belfast urban area.
Low ranking indicates highest deprivation. MDMs, Multiple Deprivation Measures; NI, Northern Ireland.
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Regression analysis
The reporting period 6 April 2020–30 May 2020 was
used for regression analysis, to provide a repeated cross-
sectional study. KCL ZOE symptom tracker app data for
NI with revised PHE case definitions and COVIDCare
NI, based on a repeated 14 day sliding window (resulting
in a 1-week overlap of data), attributed to the last day of
the period, were used for regression analysis. The 7-day
sliding window data were not used due to low number
issues for some SOAs. For both COVID-19 self-reporting
symptom mobile platforms, the data were analysed in the
form of:
►► Rates calculated as the proportion of active users
reporting symptoms for each SOA that occurred in
the defined periods of time, standardised according
to the population of each SOA. This allowed comparison of a repeated cross-sectional study of self-reported
prevalence of COVID-19 in terms of active app users
reporting PHE case definition symptoms.
►► Age-
standardised rates based on the 2011 Census
population of NI.26 The age brackets used based on
2011 Census population data (as the most comprehensive age band data available) comprised <18,
18–24, 25–34, 35–49, 50–65 and >65 years.
Generalised regression models (with log link) were
fitted between the dependent variable ‘population standardised self-reported COVID-19 symptoms’ and time as
a factor. The independent variables included area-level
deprivation indices using overall Multiple Deprivation Measures (MDM), individual deprivation domains
(adjusting p values for multiple comparisons using the
Bonferroni correction) and population household
density. All regression analysis was conducted using glm
R package and R V.4.0.0. To account for spatial autocorrelation the Moran’s I statistic and a spatial lag model,
using spatialreg R package, were used to test the residuals
computed from the regression models.34 35 Where the
Moran’s I for the residuals was found to be significantly
different from random, the generalised linear model
regression results were compared with a spatial lag model
and the model fit compared using an Akaike information
criterion.
Patient and public involvement
No patients were involved.

RESULTS
The smartphone symptom tracker apps user demographic profile is most comparable with the population
4

profile of NI for the age groups 18–24 years and 50–64
years and shows a higher percentage of users fall within
the age groups 25–34 and 35–49 years relative to the
other age groups (figure 2). The self-reporting COVID-19
symptom data represent a time series of the prevalence
of self-reported symptoms. The earlier release date of
the UK KCL ZOE symptom tracker app, compared with
the COVIDCare NI app, allowed analysis of COVID-19
self-
reporting symptom data at the earliest stages of
non-
pharmaceutical interventions and societal restrictions (‘lockdown’) in NI (14 day window data from 30
March 2020). An increase in active users of the KCL ZOE
tracker App reporting COVID-19 symptoms was observed
between 30 March 2020 and 6 April 2020, followed by a
sharp decrease after 6 April 2020 (figure 3A). The COVIDCare NI app shows a decrease in active users reporting
COVID-19 symptoms from the start of reporting period
20 April 2020 until 22 June 2020. However, there was an

Figure 3 (A) comparison of percentage of users self-
reporting COVID-19 symptom data (using data from table 1)
as provided by the KCl ZOE symptom tracker app data for NI
(reporting period 24 March 2020–22 June 2020), COVIDCare
NI symptom checker feature, (reporting period 6 April 2020–
22 June 2020) and (B) laboratory confirmed COVID-19 cases.
The dates correspond to the end date of 14-day symptom
reporting sliding window. (B) laboratory confirmed COVID-19
cases based on published data HSC NI public health agency
reports.11 HSC, health and social care; NI, Northern Ireland;
PHE, Public Health England.
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333
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for relative social deprivation, comparable to the Index of
Multiple Deprivation in England.32 33 The ranking scale is
from 1 (most deprived) to 890 (least deprived). Population household density was used as a further explanatory
variable to investigate the relationship with self-reported
COVID-1931 and was derived as the number of residents
divided by number of households for each SOA.
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increase in the percentage of COVIDCare NI app users
reporting PHE symptoms for the time period 30 May 2020
to 22 June 2020. Although the overall number of users
for both apps has decreased by this time, the increase
percentage of COVIDCare NI app users reporting symptoms may reflect the NI Public Health Agency messaging
to use the COVIDCare NI app as a triage system to
provide advice for symptoms on whether they should self-
isolate and/or seek medical assistance. Both apps show
an overall decrease in reported COVID-19 symptoms
over time which mirrors the reported peak and subsequent decline in laboratory confirmed COVID-19 cases
(figure 3B).11 Although the overall rate (per 100 000
population) of self-
reported symptoms is comparable,
the geographical coverage varies across the time periods
(figure 4A,B). The spatial maps (figure 4A,B) indicate
that KCL ZOE symptom tracker app users were located
more frequently in high population areas including
Belfast, whereas coverage for the COVIDCare NI app was
more even across NI.
Regression analysis revealed a statistically significant
negative correlation between active users of both mobile
platforms reporting symptoms and area-level deprivation
(MDM; p<0.001; table 1). These findings indicate that
throughout the reporting period, from initial lockdown
when restrictions were most stringent, the most deprived
SOAs (lowest social deprivation rankings) were associated with higher population standardised prevalence
rates of self-reported COVID-19 symptoms. A statistically
significant negative correlation was found between users
reporting COVID-19 symptoms and the area-level deprivation measures of employment (p<0.001) and living
environment (p=0.01) using data from both mobile platforms, (online supplemental table 1).
Using the mean number of residents per household
for each SOA as a proxy for population housing density
and time as a factor, a statistically significant negative
correlation, was found between prevalence rates of self-
reported COVID-19 symptoms and mean number of
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333

residents per household for both tracker apps (online
supplemental table 2). The findings indicate that higher
self-reported prevalence rates are associated with SOAs
that have a lower mean number of residents per household. This seems counterintuitive with the expectation
that higher density housing would increase the risk of
transmission. As urban areas have a greater proportion
of higher density housing, an analysis was carried out for
the Belfast urban area, the capital city of NI, UK. The
Belfast urban area comprises 150 SOAs and a population
of 287, 535 (as defined by the local government districts
identifier31). For Belfast, a statistically significant negative correlation was found between self-reported prevalence rates and social deprivation (MDM; p<0.001) for
both Symptom Tracker apps (online supplemental table
3). The findings for the urban area of Belfast are consistent with that for NI and indicate that during lockdown
restrictions, the most deprived SOAs were associated with
higher population standardised prevalence rates of self-
reported COVID-19 symptoms. However, the relationship
between population standardised prevalence rates of self-
reported COVID-19 symptoms for Belfast in relation to
housing density is quite different from that observed for
overall NI. A positive relationship is observed indicating
higher population standardised prevalence rates of self-
reported COVID-19 symptoms with higher numbers of
residents per household (p<0.001; online supplemental
table 3). The findings from the current study indicate
that higher self-reported prevalence rates are associated
with SOAs that have a higher mean number of residents
per household suggesting that higher density housing in
urban areas increases the risk of transmission.
The relationship between self-reported prevalence rates
of COVID-19 symptoms and the measures of area-level
deprivation was explored using age standardised rates of
self-reported COVID-19 symptom data using COVIDCare
NI for two 14-day time periods (ending 20 April 2020 and
11 May 2020) as these time periods provided sufficient
age standardised data within all age brackets (online
5
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Figure 4 Maps of COVID-19 symptom data for the reporting period ending 20 April 2020, provided by two sources: (A)
KCl ZOE symptom tracker app data for new PHE symptoms for Northern Ireland (reported symptoms in 592 SOAs) and (B)
COVIDCare NI symptom checker feature (reported symptoms in 758 SOAs). The date 20 April corresponds to the end date of a
14-day symptom reporting sliding window. Self-reported prevalence rates are standardised for 100 000 population. NI, Northern
Ireland; PHE, Public Health England; SOA, super output area.

Open access

Date
KCL ZOE
Intercept

Estimate
3.135

Std. error
0.0325

T value
96.505

Pr(>|t|)

Signif. codes

<2.00E-16

<0.001

06 Apr 2020

0.0002

0.0425

0.005

0.99590

13 Apr 2020

0.2441

0.0401

6.084

1.25E-09

<0.001

20 Apr 2020

0.2053

0.0431

4.77

1.89E-06

<0.001

27 Apr 2020

0.1405

0.0467

3.011

0.0026

0.001

04 May 2020

0.1508

0.0468

3.225

0.0013

<0.001

11 May 2020

0.1775

0.0465

3.82

0.0001

<0.001

18 May 2020

0.3503

0.0437

8.019

1.29E-15

<0.001

23 May 2020

0.3422

0.0449

7.627

2.8E-14

<0.001

30 May 2020
MDM

0.3662
−0.0022

0.0471
5.07E-05

7.78

8.57E-15

<0.001

−43.457

<2.00E-16

<0.001
<0.001

COVIDCare NI
Intercept

3.189

0.0327

97.495

<2e-16

27 Apr 2020

−0.0138

0.0414

−0.333

0.7391

04 May 2020

−0.0009

0.0421

−0.02

11 May 2020

0.0278

0.0424

0.654

0.5128

18 May 2020

0.0450

0.0433

1.038

0.2995

0.9837

23 May 2020

0.1341

0.0423

3.173

0.0015

0.001

30 May 2020
MDM

0.4452
−0.0005

0.0384
0.0004

11.598
−11.361

<2e-16
<2e-16

<0.001
<0.001

The dates shown correspond to the end date of the 14-day symptom reporting sliding window (resulting in a 1-week overlap
of data).
GLM, generalised linear model; HSC, health and social care; MDM, Multiple Deprivation Measure; NI, Northern Ireland.

supplemental table 4). A statistically significant negative
correlation was found between prevalence rates of self-
reported COVID-19 symptoms and area-level deprivation
for the age groups 18–24 years and 25–34 years (p<0.001
for both time periods for age group 25–34 years). In
contrast, a statistically significant positive correlation with
area-level deprivation was found for the age groups 50–64
years and >65 years (online supplemental table 4). The
results of this current study reveal a statistically significant positive relationship between self-
reported prevalence rates of COVID-19 symptoms and mean number
of residents per household (housing density) for the age
groups<18 years (for both time periods), 35–49 years
and 50–64 years (shown for time period ending 11 May;
online supplemental table 4). In contrast, a statistically
significant negative correlation with population housing
density was found for the age group 25–34 years (p<0.001
for both time periods for age group 25–34 years). A statistically significant negative correlation was found between
self-
reported prevalence rates of COVID-19 symptoms
and overall social deprivation for the age group 25–34
(p<0.001 for both time periods for age group 25–34
years).
6

DISCUSSION
Our research has shown how a lens of area-level deprivation can deepen our understanding of COVID-19 transmission and prevention. Our findings indicate that social
inequality, as measured by area-level deprivation, is associated with disparities in potential COVID-19 infection,
with higher prevalence of self-reported COVID-19 symptoms in urban areas associated with area-level deprivation,
housing density and age. The findings from the current
study provide evidence for the disproportionate adverse
effects of the interventions of societal restrictions (eg,
‘lockdown’) on areas of greater deprivation and in particular the impact of higher prevalence of self-
reported
COVID-19 symptoms in younger populations who have a
higher likelihood of living in higher density housing types
in urban areas.
There has been much debate and research on
the increased risk for the socially vulnerable during
natural and human disasters, including the COVID-19
pandemic.36–38 The pandemic has magnified the heterogeneity in society’s health burden with a disproportionately
higher impact on socially vulnerable communities.20–25
These socioeconomic inequalities are linked directly to
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333
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Table 1 Regression analysis (GLM log link), with time as a factor, of COVID-19 symptom mobile data platforms provided by
two sources: KCL ZOE symptom tracker app data for NI and HSC NI Symptom checker feature (COVIDCare NI) and covariate
area-level deprivation (MDM)
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Limitations
Our research dealt with symptom reporting, which is a
combination of (1) COVID-19-
induced symptoms and
(2) symptoms that are not due to COVID-19. Thus, the
signal measured includes COVID-19 prevalence but also
includes false positives. The reader is also reminded that
the measured signal is a function of: (1) having the requisite symptoms, (2) the propensity to report symptoms,
(3) the likelihood to participate in one or other survey,
(4) ownership of a smartphone and (5) being part of the
at-risk population. Census data for other confounders
including adult obesity and respiratory disease were not
available at SOA level.
For this research, the estimate of household density
was derived by using the mean number of residents
per household for each SOA as a proxy for population
McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333

housing density, as the address of the phone user was
not identified due to confidentiality issues. This method
suggests a uniform household size per SOA when it is
likely to be very heterogeneous. It is acknowledged that
this is a limitation of the study which may introduce inaccuracies especially where there is a small population of
app users in any SOA.
based surveilA third limitation is that symptom-
lance and the use of self-reported data may give rise to
collider bias when observational data are recorded from
non-random samples, involving voluntary participation
and self-reported symptoms, which may impact the reliability and generalisability of the findings.43 It has been
suggested that voluntary participants are more likely to
be highly educated and health conscious and, therefore,
may differ substantially from the general population.
Symptom reporting behaviour may also be different
across socioeconomic groups.44
A fourth potential limitation of the study is that self-
reporting participants came from within the adult population who had access to the use of a smartphone (estimated
to be 76% of the general NI population). However, the
use of two forms of smartphone app enabled a broader
sampling of the general population where the geographical spread of the self-reporting participants using the
different smartphone apps was investigated through
spatial mapping. The greatest geographical coverage was
reported for the 14 day period ending 20 April 2020 for
both smartphone apps (self-reporting participants from
592 SOAs and 758 SOAs for the KCL ZOE and COVIDCare NI apps, respectively; total 850 SOAs for NI). As
such, the main period for this analysis was during the first
UK lockdown, when restrictions were more severe.

CONCLUSIONS
COVID-19 symptom prevalence estimates obtained from
self-reporting COVID-19 smartphone data were regressed
on a range of socioeconomic variables in NI. Significant
associations were found between reported COVID-19
prevalence and both area-level deprivation and housing
density in urban areas for a range of age groups. The findings underline that social inequality, as measured by area-
level deprivation, creates disparities in risk of COVID-19
infection. Specifically, the results from our research
indicate a heightening of health inequalities during the
period of societal restrictions with higher self-reported
prevalence of COVID-19 symptoms associated with areas
with the greatest area-level deprivation and the lowest
deprivation rankings for employment, particularly within
the age group 18–34. This increased reporting rate in the
younger population may signal increased prevalence and
transmission of the virus, which is likely to have a negative
impact on at-risk communities. These findings, therefore,
have the potential to inform COVID-19 prevention strategies through targeted messaging to change behaviour
(‘mask’: ‘face’; ‘space’) to mitigate the disproportionate
7
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area-level deprivation indices including income, education, employment, housing and environment, which
contribute to greater risk of poor health.39–42 Our study
has shown the value of using symptom reporting to
enable a more granular exploration of social deprivation, housing density and age effect. The findings from
our research reveal that the highest self-reported prevalence rates of COVID-19 symptoms were found to be
associated with the most deprived areas (lowest social
deprivation rankings) and the most deprived areas with
lowest ranking for employment. Studies from other countries based on the same time period (March 2020–July
2020) concur with these findings in that the impact of the
SARS-CoV-2 infection was found to be higher (up to three
times higher on deprived communities.23 Other studies
indicate a link between deprivation and higher mortality
rates after infection.24
The findings from our research reveal differing relationships with the domains of area-level deprivation across
age groups. Higher self-
reported prevalence rates of
COVID-19 symptoms in the age groups 18–24 and 25oc–
34oc occurred in the most deprived areas. This finding
suggests that population density may be an important
factor for these age groups, which may not be the most
at-risk groups for the consequences of infection, but may
spread the virus through the community. This research
indicates that other factors such as area-level deprivation
are more important for the prevalence rates of COVID-19
symptoms for the age groups <18 years, 35–49 years and
50–64 years age group. Incidence across time periods was
also affected by the average number of people in a household. The current research suggests that a more in-depth
analysis by location is required to examine the influence
of rural and urban geography on the effects of area-level
deprivation and population housing density on prevalence rates of COVID-19 symptoms. The disproportionate
impact of societal restrictions (including ‘lockdown’) on
areas of greater deprivation is a cause for concern and
suggests targeted interventions (increased availability
and accessibility of testing) are required to mitigate the
impacts in areas of higher deprivation.
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